Nathalie Adda
Vice President
Biochemistry
Transgene
France
Biography
Dr. Nathalie Adda is Vice President, Chief Medical Officer and a Member of the Management Committee of Transgene SA as of November 2012. She is a Medical Doctor and a graduate of the Faculty of Medicine of the Universite Denis Diderot Paris VII where she specialized in infectious diseases. She also has a Master degree in bio-statistics. Since 2006, Dr. Adda held the position of Senior Medical Director at Vertex Pharmaceuticals in Cambridge, MA, USA, where she was responsible for the clinical development of Telaprevir, a drug approved in 2011, in the USA and Europe, for the treatment of chronic hepatitis C. Before her time at Vertex, Dr. Adda held similar roles as Associate Director, Clinical Development at Gilead, as well as at Triangle Pharmaceuticals and Boehringer Ingelheim.
Research Interest
Biochemistry, Pharmacology
